British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
This article was originally published on this website.
Zantac maker GSK agrees to pay $2.3 bn in US settlements
